Epidemiology, treatment and outcomes of infected pancreatic necrosis in France: a bicenter study - 17/04/24
Highlights |
• | No guidelines on the management of infected pancreatic necrosis exist. |
• | Treatment was unsuccessful in most patients with infected pancreatic necrosis. |
• | Blood cultures were positive in only 16% of infected pancreatic necrosis patients. |
Abstract |
Introduction |
Acute necrotizing pancreatitis (ANP) mortality increases when pancreatic necrosis is infected (IPN). Current treatment of IPN relies on prolonged antibiotic therapies associated with a step-up strategy of drainage. The objective of this study was to analyze IPN treatment outcomes in two referral centers in France.
Methods |
Data of consecutive patients with documented IPN hospitalized in two expert centers in France between 2014 and 2019 were retrospectively reviewed. The composite primary outcome was the proportion of unsuccessful management outcome, defined as new emergency drainage to treat sepsis with organ failure, an unplanned new antibiotic course, an unplanned prolongation of antibiotic course and/or death by septic shock, within three months following the diagnosis of ANP.
Results |
All in all, 187 patients (138 males; 74.0%), with documented IPN were included. The most frequently identified microorganism was Escherichia coli (26.2%). Ninety-eight patients (52.4%) were admitted to an intensive care unit or resuscitation ward within the first two days of ANP care. Overall, 126 patients (67.4%) endured an unsuccessful outcome: new emergency drainage to treat acute sepsis (62.0%), unplanned new antibiotic course (47.1%), unplanned prolongation of antibiotic course (44.9%) and/or death by septic shock complicating IPN (8.0%).
Conclusion |
The unfavorable evolution in two thirds of patients shows that determination of optimal drainage timing and choice of antibiotic therapy remain major challenges in 2024.
Le texte complet de cet article est disponible en PDF.Keywords : Acute necrotizing pancreatitis, Infected pancreatic necrosis, Intra-abdominal infection, Antibiotics, Complex infections
Plan
Vol 54 - N° 3
Article 104866- avril 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?